{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:16:29Z","timestamp":1778242589600,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC98-2320-B-037-025-MY3"],"award-info":[{"award-number":["NSC98-2320-B-037-025-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012544","name":"China Medical University, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.biopha.2017.01.104","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T17:00:59Z","timestamp":1485795659000},"page":"708-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Securinine enhances SMN2 exon 7 inclusion in spinal muscular atrophy cells"],"prefix":"10.1016","volume":"88","author":[{"given":"Yu-Chia","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Gowth","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh-Jyh","family":"Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Yee","family":"Yuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.01.104_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/NEN.0000000000000144","article-title":"Spectrum of neuropathophysiology in spinal muscular atrophy type I","volume":"74","author":"Harding","year":"2015","journal-title":"J Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.biopha.2017.01.104_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajmg.10425","article-title":"Genetic risk assessment in carrier testing for spinal muscular atrophy","volume":"110","author":"Ogino","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbadis.2014.07.024","article-title":"Molecular mechanisms and animal models of spinal muscular atrophy","volume":"1852","author":"Edens","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2017.01.104_bib0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(80)90847-8","article-title":"Classification of spinal muscular atrophies","volume":"1","author":"Pearn","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.01.104_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.01.104_bib0030","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.01.104_bib0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/498853","article-title":"Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2","volume":"78","author":"Cartegni","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy","volume":"34","author":"Kashima","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/11.5.577","article-title":"SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1","volume":"11","author":"Young","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0055","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1073\/pnas.160181697","article-title":"Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)","volume":"97","author":"Hofmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.01.104_bib0060","doi-asserted-by":"crossref","first-page":"28852","DOI":"10.1074\/jbc.M805376200","article-title":"TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing","volume":"283","author":"Bose","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.01.104_bib0065","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/MCB.00945-10","article-title":"TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy","volume":"31","author":"Singh","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2017.01.104_bib0070","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/emboj.2010.19","article-title":"The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy","volume":"29","author":"Pedrotti","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2017.01.104_bib0075","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1093\/hmg\/ddm276","article-title":"hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing","volume":"16","author":"Kashima","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0080","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/MCB.01332-08","article-title":"The RNA binding protein hnRNP Q modulates the utilization of exon 7 in the survival motor neuron 2 (SMN2) gene","volume":"28","author":"Chen","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2017.01.104_bib0085","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/11.17.2037","article-title":"hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1","volume":"11","author":"Hofmann","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0090","doi-asserted-by":"crossref","first-page":"e115205","DOI":"10.1371\/journal.pone.0115205","article-title":"Targeting SR proteins improves SMN expression in spinal muscular atrophy cells","volume":"9","author":"Wee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.01.104_bib0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1042\/BST20120016","article-title":"Small nuclear RNAs and mRNAs: linking RNA processing and transport to spinal muscular atrophy","volume":"41","author":"Sleeman","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2017.01.104_bib0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons","volume":"163","author":"Rossoll","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2017.01.104_bib0105","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/nar\/gks1224","article-title":"Implication of the SMN complex in the biogenesis and steady state level of the signal recognition particle","volume":"41","author":"Piazzon","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2017.01.104_bib0110","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1073\/pnas.230364197","article-title":"Survival motor neuron protein modulates neuron-specific apoptosis","volume":"97","author":"Kerr","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.01.104_bib0115","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1091\/mbc.e02-04-0216","article-title":"The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein","volume":"13","author":"Bachand","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2017.01.104_bib0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/cns.12242","article-title":"Gem depletion: amyotrophic lateral sclerosis and spinal muscular atrophy crossover","volume":"20","author":"Cauchi","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2017.01.104_bib0125","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbadis.2013.08.005","article-title":"Spinal muscular atrophy: an update on therapeutic progress","volume":"1832","author":"Seo","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2017.01.104_bib0130","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.gt.3301550","article-title":"An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA","volume":"8","author":"Zhang","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2017.01.104_bib0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2007.11.012","article-title":"The effect of hydroxyurea in spinal muscular atrophy cells and patients","volume":"268","author":"Liang","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2017.01.104_bib0140","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"Chang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.01.104_bib0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/aja.1001940306","article-title":"Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.biopha.2017.01.104_bib0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(85)90014-9","article-title":"Securinine alkaloids: a new class of GABA receptor antagonist","volume":"330","author":"Beutler","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.01.104_bib0155","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","article-title":"A novel nuclear structure containing the survival of motor neurons protein","volume":"15","author":"Liu","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2017.01.104_bib0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.fitote.2008.02.011","article-title":"Securinega suffruticosa","volume":"79","author":"Raj","year":"2008","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2017.01.104_bib0170","series-title":"The Pharmacology of Chinese Herbs","author":"Huang","year":"1998"},{"key":"10.1016\/j.biopha.2017.01.104_bib0175","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.1971.03190230048010","article-title":"Medical education and care in People's Republic of China","volume":"218","author":"Dimond","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2017.01.104_bib0180","doi-asserted-by":"crossref","first-page":"e21203","DOI":"10.1371\/journal.pone.0021203","article-title":"Securinine, a myeloid differentiation agent with therapeutic potential for AML","volume":"6","author":"Gupta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.01.104_bib0185","first-page":"36","article-title":"From Asia securinine\u2013a central nervous stimulant is used in treatment of amytrophic lateral sclerosis","volume":"76","author":"Copperman","year":"1973","journal-title":"Pa Med."},{"key":"10.1016\/j.biopha.2017.01.104_bib0190","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1096\/fj.09-148999","article-title":"Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells","volume":"24","author":"Rana","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2017.01.104_bib0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.31083\/ph.2014.3802","article-title":"Antiproliferative activity and apoptosis-inducing mechanism of L-securinine on human breast cancer MCF-7 cells","volume":"69","author":"Li","year":"2014","journal-title":"Pharmazie"},{"key":"10.1016\/j.biopha.2017.01.104_bib0200","first-page":"161","article-title":"Valproate and spinal muscular atrophy (Review)","volume":"1","author":"Natasha","year":"2008","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2017.01.104_bib0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2377-11-36","article-title":"Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid","volume":"11","author":"Darbar","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.biopha.2017.01.104_bib0210","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmg.2010.080366","article-title":"Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design","volume":"47","author":"Tiziano","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","article-title":"Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients","volume":"13","author":"Brahe","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2017.01.104_bib0220","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216323137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216323137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:05:51Z","timestamp":1778241951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216323137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":44,"alternative-id":["S0753332216323137"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.104","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Securinine enhances SMN2 exon 7 inclusion in spinal muscular atrophy cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}